Adenomyosis that goes untreated tends to get worse over time, not better. Over a 12-month period, roughly 31% of women who don’t use hormonal treatment experience measurable disease progression, compared to about 18% of those on hormonal therapy. That progression means heavier bleeding, worsening pain, a growing uterus, and a cascade of secondary problems that can affect everything from your energy levels to your mental health. The condition does typically resolve after menopause when estrogen levels drop, but for many women that’s years or even decades away.
How Symptoms Change Over Time
Adenomyosis is driven by estrogen. The endometrial tissue that has grown into the muscular wall of the uterus responds to your monthly hormonal cycle, swelling and bleeding with each period. As long as you’re menstruating, that tissue continues to be stimulated. In many women, the result is a slow escalation: periods get heavier, cramps become more intense, and pain starts showing up outside of menstruation altogether.
Research tracking untreated patients found that those who already had moderate to severe menstrual pain, chronic pelvic pain, or painful bowel movements were at the highest risk of progression. Pain that worsens between appointments is itself a predictor that the disease is advancing. Women with a specific subtype where the tissue invades the outer layer of the uterine muscle also progressed more often. So the trajectory isn’t the same for everyone, but the overall direction without treatment is toward more symptoms, not fewer.
Heavy Bleeding and Anemia
One of the most concrete consequences of untreated adenomyosis is iron-deficiency anemia from chronic heavy menstrual bleeding. In one study comparing women with adenomyosis to other gynecological groups, 61.6% of the adenomyosis patients were anemic. That’s not a minor lab finding. Anemia at that level means persistent fatigue, dizziness, shortness of breath during normal activities, brain fog, and pale skin. Over months and years, your body’s iron stores deplete further with each heavy period.
In severe cases, the blood loss can trigger more dangerous complications involving abnormal blood clotting and, rarely, organ damage. Even in less extreme scenarios, chronic anemia chips away at your quality of life in ways that are easy to dismiss as “just being tired” until the cumulative effect becomes impossible to ignore.
Effects on Fertility and Pregnancy
If you’re trying to conceive, untreated adenomyosis creates real obstacles. In one study of 103 patients, over 55% had infertility, and nearly 9% experienced recurrent miscarriages. The first-trimester miscarriage rate is consistently higher in women with adenomyosis compared to those without it. One study using donor eggs (which removes egg quality as a variable) found that the miscarriage rate in women with adenomyosis was 13.1%, nearly double the 7.2% rate in the control group. That points to a problem with the uterine environment itself, not just the eggs or embryos.
The exact mechanisms aren’t fully understood, but the disrupted uterine lining and altered muscle contractions likely interfere with implantation and early pregnancy maintenance. Some women with adenomyosis who had repeated IVF failures saw improved outcomes after surgical treatment, suggesting the disease itself was the barrier.
The Uterus Continues to Enlarge
Adenomyosis causes the uterus to become enlarged and more rounded (sometimes called “globular”). Without treatment, this process continues. The inner boundary between the uterine lining and the muscle wall, called the junctional zone, progressively thickens. On imaging, doctors track this thickness as a marker of severity. A junctional zone over 12 mm on MRI is a hallmark of established adenomyosis, and in advanced cases, the tissue can infiltrate through more than two-thirds of the uterine wall.
A larger uterus contributes to pelvic pressure, bloating, urinary frequency, and the feeling of heaviness in the lower abdomen that many women describe. It can also make periods heavier simply because there’s more surface area of abnormal tissue responding to each hormonal cycle.
Connection to Endometriosis and Compounding Symptoms
Adenomyosis rarely exists in isolation. Among women with endometriosis and infertility, adenomyosis is found at rates between 35% and 79%. In those with endometriosis and pelvic pain, the overlap ranges from 38% to 87%. When both conditions are present and untreated, the symptom burden compounds: more pain, heavier bleeding, greater impact on fertility, and a harder time pinpointing which condition is driving which symptom.
Mental Health and Daily Functioning
The toll of living with untreated adenomyosis goes well beyond the physical symptoms. A comparative study found that women with adenomyosis scored significantly higher for both anxiety and depression than women without the condition. Their anxiety scores averaged 10.1 out of 21 compared to 6.9 in the control group, and depression scores were more than double (6.4 versus 2.7).
The impact on work and daily life was striking. Women with adenomyosis missed 12.2% of their work hours due to illness, compared to just 1.1% for women without it. Even when they showed up, presenteeism (being at work but functioning poorly) affected 31% of their productive time. Overall work productivity loss hit 38%, and impairment in daily activities outside of work reached nearly 56%. Every quality-of-life domain measured, from physical functioning to social activities to emotional well-being, was significantly lower in the adenomyosis group.
Cancer Risk
The relationship between adenomyosis and cancer is a common worry, and the evidence is mostly reassuring. Malignant transformation of adenomyosis tissue itself is very rare, occurring in roughly 1% of cases. Endometrial cancer can coexist with adenomyosis, but that doesn’t mean the adenomyosis caused it. In a large study of over 85,000 women with adenomyosis, 1.65% developed endometrial cancer, a rate that doesn’t clearly separate from background risk once other factors are considered.
That said, adenomyosis and certain cancers share underlying drivers: chronic inflammation, hormonal imbalance, immune dysregulation, and genetic factors. When cancer does arise directly from adenomyosis tissue (as opposed to simply appearing alongside it), it tends to carry a worse prognosis, with lower rates of hormonal receptor expression that limit treatment options. This is uncommon enough that it shouldn’t drive treatment decisions on its own, but it’s part of the full picture.
What Happens at Menopause
Because adenomyosis depends on estrogen, symptoms typically resolve after menopause. The tissue stops being stimulated, bleeding ends, and pain usually fades. For women diagnosed in their late 40s, this natural endpoint may be close enough that managing symptoms conservatively makes sense. For someone diagnosed at 30, though, “waiting for menopause” means potentially two decades of progressive symptoms, worsening anemia, and diminished quality of life. The calculus is different depending on your age, your symptoms, and whether fertility matters to you.
Hormone replacement therapy after menopause can, in some cases, restimulate adenomyosis tissue, so even the post-menopausal picture isn’t always straightforward for women who need HRT for other reasons.